UNC research uncovers evidence of human susceptibility to emerging coronavirus strain in swine
October 12, 2020 New research from the Baric Lab suggests that an emerging strain of coronavirus known as swine acute diarrhea syndrome coronavirus (SADS-CoV) may have the potential to spread to humans as well.
Black women with breast cancer experience delayed, longer treatment than white women
October 5, 2020 One in seven Black women with breast cancer had delays in starting treatment, and Black women also had extended duration of treatment, according to a study led by researchers from the UNC-Chapel Hill Gillings School of Global Public Health and UNC's Lineberger Comprehensive Cancer Center.
Benefield honored with Michael S. O’Malley Alumni Award for research to identify racial differences in breast cancer outcomes
September 18, 2020 Halei Benefield has been named the 2020 recipient of the Michael S. O’Malley Alumni Award for Publication Excellence in Cancer Population Sciences.
Could drones be the key to increasing defibrillator use during a heart attack?
September 16, 2020 Each year, more than 350,000 out-of-hospital cardiac arrests take place in the United States. An estimated 90% of the people who experience one do not survive. In a study published in the New England Journal of Medicine, a team led by Dr. Wayne Rosamond describes a new method to give bystanders life-saving access to AEDs: drone delivery.
Building early warning systems against pandemic threats
August 31, 2020 The nonprofit EcoHealth Alliance has announced its latest program: The Emerging Infectious Diseases Southeast Asia Research Collaboration Hub. This is one of a new group of research centers supported by the National Institute of Allergy and Infectious Diseases, and faculty at the UNC Gillings School are key collaborators.
Mouse-adapted SARS-CoV-2 model provides new tool for COVID-19 discoveries
August 31, 2020 A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a vaccine candidate to clinical trial.
Single-shot COVID-19 vaccine protects non-human primates
August 10, 2020 The development of a safe and effective vaccine is a key step in ending the COVID-19 pandemic. A group of scientists now report that a leading candidate COVID-19 vaccine raises neutralizing antibodies and robustly protects non-human primates against SARS-CoV-2, the virus that causes COVID-19.
NSF funds UNC scientists to explore potential COVID-19 aerosol transmission
August 3, 2020 In an effort to further our understanding of how COVID-19 is spread, the National Science Foundation has funded a team of researchers at the Gillings School, led by Dr. Barbara Turpin, to study the SARS-CoV-2 virus' potential for aerosol transmission.
Antibody research shows promise in fight against COVID-19
July 23, 2020 Based on positive results published as a preclinical study, potently neutralizing antibodies show promise as a therapy for preventing and treating COVID-19. The monoclonal antibodies were isolated from the blood of a couple from Wuhan, China, who were diagnosed with COVID-19.
UNC researchers discuss pitfalls of convenience samples for COVID-19 antibody testing
July 23, 2020 Drs. Alison Aiello and Bonnie Shook-Sa of the UNC Gillings School and Dr. Ross Boyce of the UNC School of Medicine published a viewpoint piece on the downsides of certain types of early SARS-CoV-2 seroprevalence studies.
